Skip to main content
UC Davis Health System

UC Davis Health System

FEATURE | Posted Sept. 6, 2013

College student wins scholarship for essay about cancer experience

Keaton Raphael Memorial awards Arianna Lawson-Price $1,000

Arianna on the left and the executive director of the Keaton Raphael Memorial,  Teresa Hofhenke
Arianna Lawson-Price, on the left, receives scholarship check from Teresa Hofhenke, executive director of the Keaton Raphael Memorial.

A 20-year-old Colfax woman and former cancer center patient was awarded a $1,000 college scholarship recently by the Keaton Raphael Memorial, a Roseville philanthropy that supports families affected by childhood cancer.

Arianna Lawson-Price, who was treated at the UC Davis Comprehensive Cancer Center for stage IV, large B-Cell non-Hodgkins lymphoma in 2008, won the John McLean Hero Award scholarship for an essay she wrote about her experience with the disease.

Keaton Raphael Memorial created the award to help childhood cancer survivors with college expenses. John McLean, a long-time supporter of the fight against childhood cancer, lost his own battle with the disease.

Part of Lawson-Price’s essay was read aloud at the Memorial’s 16th annual “Chipping Away at Childhood Cancer” golf tournament on Aug. 19. She wrote:

“Life is a series of events unfolding in random fashion, and most humans (if they are fortunate enough) get a lifetime to experience them. But for a child with cancer these experiences happen faster than anticipated. It is said that with age comes wisdom. I respectfully disagree. I believe that with experience comes wisdom. My experience with childhood cancer has given me wisdom that was achieved at a very early age, and has a result, has made me a better person.”

Lawson-Price completed her general education requirements at Sierra College and transferred this fall to Sacramento State University with a major in Psychology. She eventually hopes to get her Master’s degree in Social Work and become a childcare specialist working with children with cancer and other life-threatening illnesses.